These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13198007)

  • 21. [EXAMINATION OF TOTAL SERUM LIPIDS, TOTALS SERUM LIPIDS, TOTAL SERUM CHOLESTEROL AND LIPOPROTEIN FRACTIONS IN DIABETES MELLITUS].
    SZUCS Z; CSAPO G; LASZLO IK
    Orv Hetil; 1964 May; 105():924-8. PubMed ID: 14159634
    [No Abstract]   [Full Text] [Related]  

  • 22. A study in the pathogenesis of hyperlipemia in a patient with acromegaly and diabetes mellitus.
    Camitta FD; Gray TK
    Diabetes; 1969 Jan; 18(1):44-50. PubMed ID: 5761868
    [No Abstract]   [Full Text] [Related]  

  • 23. [DIABETES AND LIPOATROPHY].
    BONARD EC; VERNET A
    Rev Med Suisse Romande; 1964 Dec; 84():905-12. PubMed ID: 14248061
    [No Abstract]   [Full Text] [Related]  

  • 24. SERUM LIPID ABNORMALITIES IN DIABETES MELLITUS.
    SULLIVAN JF; LANKFORD HG; GRINNELL EH
    Curr Ther Res Clin Exp; 1965 Jan; 7():28-34. PubMed ID: 14246366
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lipotoxicity and glycemic regulation].
    Avignon A; Picard S
    Diabetes Metab; 1999 Sep; 25(3):275-82. PubMed ID: 10499199
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection and management of lipid disorders in diabetes. American Diabetes Association.
    Diabetes Care; 1993 May; 16(5):828-34. PubMed ID: 8495626
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDY ON THE TOTAL SERUM LIPOID LEVEL AND LIPOPROTEIN FRACTIONS IN DIABETICS TREATED WITH INSULIN AND BUCARBAN].
    SZUECS Z; CSAPO G
    Orv Hetil; 1963 Nov; 104():2170-1. PubMed ID: 14098522
    [No Abstract]   [Full Text] [Related]  

  • 28. [ON THE EFFECT OF SERUM LIPID CONCENTRATION ON THE I-131-TRIOLEIN TOLERANCE TEST].
    JUNG GF; JAHNKE K; BREITBACH A
    Z Gesamte Exp Med; 1963 Dec; 137():554-60. PubMed ID: 14124496
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipids and lipoproteins in untreated diabetes.
    Roe RL; Walsh EJ
    Lancet; 1969 Aug; 2(7618):496-7. PubMed ID: 4183927
    [No Abstract]   [Full Text] [Related]  

  • 30. [THE SIGNIFICANCE OF THE CHANGES IN PLASMATIC POLYUNSATURATED ACIDS IN BLOOD LIPID DISORDERS].
    VITELLI A; MATTEIGRANDIS C; CATTANEO C
    Minerva Med; 1963 Dec; 54():3804-16. PubMed ID: 14115940
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum lipids in lipemia retinalis: report of a case.
    FRANKLIN EC; WEISSMAN M
    Ann Intern Med; 1957 Feb; 46(2):413-9. PubMed ID: 13403526
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid disorders in diabetes mellitus.
    Avogaro P; Capri C; Cazzolato G
    Isr J Med Sci; 1972 Jun; 8(6):832. PubMed ID: 4626314
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of fatty liver as an early symptom of diabetes mellitus and hyperlipoproteinemias].
    Hanefeld M; Haller H; Renger F; Stötzner H
    Dtsch Z Verdau Stoffwechselkr; 1974; 34(5-6):299-300. PubMed ID: 4471587
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipids and diabetes: the case for treatment of macrovascular disease.
    Eaton RP
    Diabetes Care; 1979; 2(1):46-50. PubMed ID: 510108
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipid disorders in diabetes mellitus.
    Kern PA
    Mt Sinai J Med; 1987 Mar; 54(3):245-52. PubMed ID: 3295530
    [No Abstract]   [Full Text] [Related]  

  • 36. CHARACTERIZATION OF FAT PARTICLES IN PLASMA OF HYPERLIPEMIC SUBJECTS MAINTAINED ON FAT-FREE HIGH-CARBOHYDRATE DIETS.
    BIERMAN EL; PORTE D; O'HARA DD; SCHWARTZ M; WOOD FC
    J Clin Invest; 1965 Feb; 44(2):261-70. PubMed ID: 14260869
    [No Abstract]   [Full Text] [Related]  

  • 37. METABOLIC EFFECTS OF GORGING VERSUS NIBBLING.
    GWINUP G; KRUGER FA; HAMWI GJ
    Ohio State Med J; 1964 Jul; 60():663-6. PubMed ID: 14159622
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparison of effect between multiplex and simplex nutritional intervention on hyperlipemia, hypertension or diabetes].
    Zhai C; Zhang J; Zhai Y; Chen J; Zuo H; Jiang L
    Wei Sheng Yan Jiu; 2004 Nov; 33(6):719-21. PubMed ID: 15727187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and management of lipid disorders in diabetic patients. A commentary for clinicians.
    Garber AJ; Vinik AI; Crespin SR
    Diabetes Care; 1992 Aug; 15(8):1068-74. PubMed ID: 1303635
    [No Abstract]   [Full Text] [Related]  

  • 40. ADA issues management guidelines for lipid disorders in diabetics.
    Am Fam Physician; 1993 Mar; 47(4):992, 994. PubMed ID: 8438690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.